Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013
- 346 Downloads
Purpose of Review
Post-traumatic nightmares (PTN) are a common and enduring problem for individuals with post-traumatic stress disorder (PTSD) and other clinical presentations. PTN cause significant distress, are associated with large costs, and are an independent risk factor for suicide. Pharmacological and non-pharmacological treatment options for PTN exist. A previous review in this journal demonstrated that Prazosin, an alpha blocker, was a preferred pharmacological treatment for PTN and imagery rescripting therapy (IRT) was a preferred non-pharmacological treatment. Since that time, new and important research findings create the need for an updated review.
Based on the results of a recent study in the New England Journal of Medicine, Prazosin has been downgraded by both the American Academy of Sleep Medicine (AASM) and the Veterans Health Administration/Department of Defense (VA/DoD) for PTN. In Canada, Nabilone, a synthetic cannabinoid, appears to be promising. Few recent studies have been published on non-pharmacological interventions for PTN; however, recent data is available with regard to using IRT on an inpatient setting, with German combat veterans, and through the use of virtual technology. Recent evidence supports the use of exposure, relaxation, and rescripting therapy (ERRT) with children and individuals with comorbid bipolar disorder and PTN.
Prazosin is no longer considered a first-line pharmacological intervention for PTN by AASM and VA/DoD. However, in the absence of a suitable alternative, it will likely remain the preferred option of prescribers. IRT and ERRT remain preferred non-pharmacological treatments of PTN. Combining cognitive behavior therapy for insomnia (CBT-I) with IRT or ERRT may lead to improved outcomes.
KeywordsNightmares Trauma Traumatic PTSD Trauma nightmare Prazosin Imagery rehearsal therapy
Compliance with Ethical Standards
Conflict of Interest
Scott H. Waltman worked as a consultant and CBT trainer for the Academy of Cognitive Therapy.
David Shearer declares no potential conflicts of interest.
Bret A. Moore reports he is a CME content reviewer for the Neuroscience Education Institute and Series Editor for Routledge Press book series titled “Clinical Topics in Psychology and Psychiatry.”
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Cushway D, Sewell R. Therapy with dreams and nightmares. 2nd ed. London: Sage; 2013.Google Scholar
- 2.Freud S. The interpretation of dreams. Harmondsworth: Penguin; 1899/1976.Google Scholar
- 3.American Academy of Sleep Medicine, European Sleep Research Society, the Japanese Society of Sleep Research, the Latin American Sleep Society. International Classification of Sleep Disorders. Westchester, IL: American Academy of Sleep Medicine; 2001.Google Scholar
- 4.Herman JL. Trauma and recovery: the aftermath of violence—from domestic abuse to political terror. Hachette: Basic Books; 1992.Google Scholar
- 11.•• Ho FY, Chan CS, Tang KN. Cognitive-behavioral therapy for sleep disturbances in treating posttraumatic stress disorder symptoms: a meta-analysis of randomized controlled trials. Clin Psychol Rev. 2016;43:90–102 This article is the most comprehensive article available regarding RCTs for PTSD symptoms that includes posttraumatic nightmares. CrossRefPubMedGoogle Scholar
- 12.Larsen SE, Fleming CJ, Resick PA. Residual symptoms following empirically supported treatment for PTSD. Psychol Trauma Theory Res Pract Policy. 2018. https://doi.org/10.1037/tra0000384.
- 15.• Escamilla M, LaVoy M, Moore BA, Krakow B. Management of post-traumatic nightmares: a review of pharmacologic and nonpharmacologic treatments since 2010. Curr Psychiatry Rep. 2012;14(5):529–35 This article reviews the literature between 2010 and 2013 for both pharmacological and non-pharmacological treatments for posttraumatic nightmares. CrossRefPubMedGoogle Scholar
- 18.• Ellis TE, Rufino KA, Nadorff MR. Treatment of nightmares in psychiatric inpatients with imagery rehearsal therapy: an open trial and case series. Behav Sleep Med. 2017. https://doi.org/10.1080/15402002.2017.1299738 This article reviews Imagery Rehearsal Therapy in an inpatient setting, which expands the data supporting its use with different populations.
- 20.Mysliwiec V, O'Reilly B, Polchinski J, Kwon HP, Germain A, Roth BJ. Trauma associated sleep disorder: a proposed parasomnia encompassing disruptive nocturnal behaviors, nightmares, and REM without atonia in trauma survivors. J Cl Sleep Med. 2014;10(10):1143–8.Google Scholar
- 26.Department of Veterans Affairs, Department of Defense. VA/DoD clinical practice guidelines for the management of posttraumatic stress disorder and acute stress disorder. 2017. https://www.healthquality.va.gov/guidelines/MH/ptsd/VADoDPTSDCPGFinal.pdf Accessed 26 Jun 2018
- 27.•• Raskind MA, Peskind ER, Chow B, Harris C, Davis-Karim A, Holmes HA, et al. Trial of prazosin for post-traumatic stress disorder in military veterans. N Engl J Med. 2018;378(6):507–17 This results of this study influenced prazosin’s downgrade in the Clinical Practice Guidelines for the Management of Posttraumatic Stress Disorder from the Department of Veterans Affairs and the Department of Defense and the American Academy of Sleep Medicine. CrossRefPubMedGoogle Scholar
- 33.Raskind MA, Peskind ER, Kanter ED, Petrie EC, Radant A. Thompson CE,, et al. reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. PsychiatryOnline. 2003;160(2):371–3.Google Scholar
- 42.Nirmalani-Gandhy A, Sanchez D, Catalano G. Terazosin for the treatment of trauma-related nightmares. Cl Neuropharmacology. 2015;38(3):109–11.Google Scholar
- 44.Sethi R, Vasudeva S. Doxazosin for the treatment of nightmares. Prim Care Companion CNS Disord. 2012. https://doi.org/10.4088/pcc.12l01356.
- 75.Stein DJ, Pedersen R, Rothbaum BO, Baldwin DS, Ahmed S, Musgnung J, et al. Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis. Int J Neuropsychopharmacol. 2005;12(01):23.CrossRefGoogle Scholar
- 79.Alliger-Horn C, Zimmermann P, Herr K, Danker-Hopfe H, Willmund G. Adapted, inpatient nightmare therapy involving imagery rehearsal therapy (IRT) for chronically war-traumatized German soldiers with PTSD. Z Psychiatr Psychol Psychother. 2017;65(4):251–60.Google Scholar
- 80.Sheaves B, Onwumere J, Keen N, Kuipers E. Treating your worst nightmare: a case-series of imagery rehearsal therapy for nightmares in individuals experiencing psychotic symptoms. Cog Behav Therap. 2015;8. https://doi.org/10.1017/S1754470X15000665.
- 87.Colvonen PJ, Drummond SP, Angkaw AC, Norman SB. Cognitive behavioral therapy for insomnia integrated with prolonged exposure: rationale and pilot study. Psychol Trauma Under Rev.Google Scholar
- 89.Defense Health Agency. Dream EZ. http://t2health.dcoe.mil/dream-ez Accessed 26 Jun 2018.
- 95.Waltman SH, Creed TA, Beck AT. Are the effects of cognitive behavior therapy for depression falling? Review and critique of the evidence. Clin Psychol. 2016;23(2):113–22.Google Scholar